These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Exploring the Druggability of Conserved RNA Regulatory Elements in the SARS-CoV-2 Genome. Sreeramulu S; Richter C; Berg H; Wirtz Martin MA; Ceylan B; Matzel T; Adam J; Altincekic N; Azzaoui K; Bains JK; Blommers MJJ; Ferner J; Fürtig B; Göbel M; Grün JT; Hengesbach M; Hohmann KF; Hymon D; Knezic B; Martins JN; Mertinkus KR; Niesteruk A; Peter SA; Pyper DJ; Qureshi NS; Scheffer U; Schlundt A; Schnieders R; Stirnal E; Sudakov A; Tröster A; Vögele J; Wacker A; Weigand JE; Wirmer-Bartoschek J; Wöhnert J; Schwalbe H Angew Chem Int Ed Engl; 2021 Aug; 60(35):19191-19200. PubMed ID: 34161644 [TBL] [Abstract][Full Text] [Related]
4. Development of potent and selective inhibitors targeting the papain-like protease of SARS-CoV-2. Shan H; Liu J; Shen J; Dai J; Xu G; Lu K; Han C; Wang Y; Xu X; Tong Y; Xiang H; Ai Z; Zhuang G; Hu J; Zhang Z; Li Y; Pan L; Tan L Cell Chem Biol; 2021 Jun; 28(6):855-865.e9. PubMed ID: 33979649 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of kinetics and thermodynamics of interaction between immobilized SARS-CoV-2 nucleoprotein and specific antibodies by total internal reflection ellipsometry. Plikusiene I; Maciulis V; Ramanaviciene A; Balevicius Z; Buzavaite-Verteliene E; Ciplys E; Slibinskas R; Simanavicius M; Zvirbliene A; Ramanavicius A J Colloid Interface Sci; 2021 Jul; 594():195-203. PubMed ID: 33761394 [TBL] [Abstract][Full Text] [Related]
8. A COVID moonshot: assessment of ligand binding to the SARS-CoV-2 main protease by saturation transfer difference NMR spectroscopy. Kantsadi AL; Cattermole E; Matsoukas MT; Spyroulias GA; Vakonakis I J Biomol NMR; 2021 May; 75(4-5):167-178. PubMed ID: 33856612 [TBL] [Abstract][Full Text] [Related]
9. SCoV2-MD: a database for the dynamics of the SARS-CoV-2 proteome and variant impact predictions. Torrens-Fontanals M; Peralta-García A; Talarico C; Guixà-González R; Giorgino T; Selent J Nucleic Acids Res; 2022 Jan; 50(D1):D858-D866. PubMed ID: 34761257 [TBL] [Abstract][Full Text] [Related]
10. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening. Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303 [TBL] [Abstract][Full Text] [Related]
11. The COVID19-NMR Consortium: A Public Report on the Impact of this New Global Collaboration. Duchardt-Ferner E; Ferner J; Fürtig B; Hengesbach M; Richter C; Schlundt A; Sreeramulu S; Wacker A; Weigand JE; Wirmer-Bartoschek J; Schwalbe H Angew Chem Int Ed Engl; 2023 Mar; 62(14):e202217171. PubMed ID: 36748955 [TBL] [Abstract][Full Text] [Related]
12. Targeting SARS-CoV-2 main protease: structure based virtual screening, in silico ADMET studies and molecular dynamics simulation for identification of potential inhibitors. Uniyal A; Mahapatra MK; Tiwari V; Sandhir R; Kumar R J Biomol Struct Dyn; 2022 May; 40(8):3609-3625. PubMed ID: 33226303 [TBL] [Abstract][Full Text] [Related]
13. Large-Scale Recombinant Production of the SARS-CoV-2 Proteome for High-Throughput and Structural Biology Applications. Altincekic N; Korn SM; Qureshi NS; Dujardin M; Ninot-Pedrosa M; Abele R; Abi Saad MJ; Alfano C; Almeida FCL; Alshamleh I; de Amorim GC; Anderson TK; Anobom CD; Anorma C; Bains JK; Bax A; Blackledge M; Blechar J; Böckmann A; Brigandat L; Bula A; Bütikofer M; Camacho-Zarco AR; Carlomagno T; Caruso IP; Ceylan B; Chaikuad A; Chu F; Cole L; Crosby MG; de Jesus V; Dhamotharan K; Felli IC; Ferner J; Fleischmann Y; Fogeron ML; Fourkiotis NK; Fuks C; Fürtig B; Gallo A; Gande SL; Gerez JA; Ghosh D; Gomes-Neto F; Gorbatyuk O; Guseva S; Hacker C; Häfner S; Hao B; Hargittay B; Henzler-Wildman K; Hoch JC; Hohmann KF; Hutchison MT; Jaudzems K; Jović K; Kaderli J; Kalniņš G; Kaņepe I; Kirchdoerfer RN; Kirkpatrick J; Knapp S; Krishnathas R; Kutz F; Zur Lage S; Lambertz R; Lang A; Laurents D; Lecoq L; Linhard V; Löhr F; Malki A; Bessa LM; Martin RW; Matzel T; Maurin D; McNutt SW; Mebus-Antunes NC; Meier BH; Meiser N; Mompeán M; Monaca E; Montserret R; Mariño Perez L; Moser C; Muhle-Goll C; Neves-Martins TC; Ni X; Norton-Baker B; Pierattelli R; Pontoriero L; Pustovalova Y; Ohlenschläger O; Orts J; Da Poian AT; Pyper DJ; Richter C; Riek R; Rienstra CM; Robertson A; Pinheiro AS; Sabbatella R; Salvi N; Saxena K; Schulte L; Schiavina M; Schwalbe H; Silber M; Almeida MDS; Sprague-Piercy MA; Spyroulias GA; Sreeramulu S; Tants JN; Tārs K; Torres F; Töws S; Treviño MÁ; Trucks S; Tsika AC; Varga K; Wang Y; Weber ME; Weigand JE; Wiedemann C; Wirmer-Bartoschek J; Wirtz Martin MA; Zehnder J; Hengesbach M; Schlundt A Front Mol Biosci; 2021; 8():653148. PubMed ID: 34041264 [TBL] [Abstract][Full Text] [Related]
14. Mapping major SARS-CoV-2 drug targets and assessment of druggability using computational fragment screening: Identification of an allosteric small-molecule binding site on the Nsp13 helicase. Freidel MR; Armen RS PLoS One; 2021; 16(2):e0246181. PubMed ID: 33596235 [TBL] [Abstract][Full Text] [Related]
15. Bung N; Krishnan SR; Bulusu G; Roy A Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764 [No Abstract] [Full Text] [Related]
16. Combining Different Docking Engines and Consensus Strategies to Design and Validate Optimized Virtual Screening Protocols for the SARS-CoV-2 3CL Protease. Manelfi C; Gossen J; Gervasoni S; Talarico C; Albani S; Philipp BJ; Musiani F; Vistoli G; Rossetti G; Beccari AR; Pedretti A Molecules; 2021 Feb; 26(4):. PubMed ID: 33557115 [TBL] [Abstract][Full Text] [Related]
18. Intrinsically Disordered Proteins: Perspective on COVID-19 Infection and Drug Discovery. Tenchov R; Zhou QA ACS Infect Dis; 2022 Mar; 8(3):422-432. PubMed ID: 35196007 [TBL] [Abstract][Full Text] [Related]
19. Jumping from Fragment to Drug via Smart Scaffolds. Farahani MD; França TCC; Alapour S; Shahout F; Boulon R; Iddir M; Maddalena M; Ayotte Y; LaPlante SR ChemMedChem; 2022 May; 17(10):e202200092. PubMed ID: 35298873 [TBL] [Abstract][Full Text] [Related]
20. TMPRSS2 and RNA-Dependent RNA Polymerase Are Effective Targets of Therapeutic Intervention for Treatment of COVID-19 Caused by SARS-CoV-2 Variants (B.1.1.7 and B.1.351). Lee J; Lee J; Kim HJ; Ko M; Jee Y; Kim S Microbiol Spectr; 2021 Sep; 9(1):e0047221. PubMed ID: 34378968 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]